ATE273708T1 - Wirkstoff zur prophylaxis und behandlung von krankheiten durch thromboxane a2 vermittelt - Google Patents

Wirkstoff zur prophylaxis und behandlung von krankheiten durch thromboxane a2 vermittelt

Info

Publication number: ATE273708T1
Authority: AT; Austria
Prior art keywords: txa2; prophylaxis; treatment; pct; mediated diseases
Prior art date: 1994-02-22

Application number

AT95909122T

Other languages

English (en)

Inventor

Ruriko Ikegawa

Teruaki Imada

Norifumi Nakamura

Keizo Tanikawa

Nobutomo Tsuruzoe

Original Assignee

Nissan Chemical Ind Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-02-22

Filing date

1995-02-20

Publication date

2004-09-15

1995-02-20 Application filed by Nissan Chemical Ind Ltd filed Critical Nissan Chemical Ind Ltd

2004-09-15 Application granted granted Critical

2004-09-15 Publication of ATE273708T1 publication Critical patent/ATE273708T1/de

Links

201000010099 disease Diseases 0.000 title abstract 4
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 4
DSNBHJFQCNUKMA-SCKDECHMSA-N thromboxane A2 Chemical compound OC(=O)CCC\C=C/C[C@@H]1[C@@H](/C=C/[C@@H](O)CCCCC)O[C@@H]2O[C@H]1C2 DSNBHJFQCNUKMA-SCKDECHMSA-N 0.000 title abstract 4
238000011321 prophylaxis Methods 0.000 title abstract 3
238000011282 treatment Methods 0.000 title abstract 3
239000004480 active ingredient Substances 0.000 title abstract 2
102000003960 Ligases Human genes 0.000 abstract 3
108090000364 Ligases Proteins 0.000 abstract 3
230000001404 mediated effect Effects 0.000 abstract 3
239000003795 chemical substances by application Substances 0.000 abstract 2
239000003112 inhibitor Substances 0.000 abstract 2
-1 pyridazinone compound Chemical class 0.000 abstract 2
150000003839 salts Chemical class 0.000 abstract 2
230000002401 inhibitory effect Effects 0.000 abstract 1
230000000069 prophylactic effect Effects 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Urology & Nephrology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Endocrinology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pulmonology (AREA)
Vascular Medicine (AREA)
Diabetes (AREA)
Reproductive Health (AREA)
Hematology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Confectionery (AREA)
Pyridine Compounds (AREA)

AT95909122T 1994-02-22 1995-02-20 Wirkstoff zur prophylaxis und behandlung von krankheiten durch thromboxane a2 vermittelt ATE273708T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2455694		1994-02-22
PCT/JP1995/000244 WO1995022329A1 (en)	1994-02-22	1995-02-20	Agent for prophylaxis and treatment of thromboxane a2-mediated diseases

Publications (1)

Publication Number	Publication Date
ATE273708T1 true ATE273708T1 (de)	2004-09-15

Family

ID=12141437

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT95909122T ATE273708T1 (de)	1994-02-22	1995-02-20	Wirkstoff zur prophylaxis und behandlung von krankheiten durch thromboxane a2 vermittelt

Country Status (16)

Country	Link
US (1)	US5798357A (de)
EP (1)	EP0744950B1 (de)
JP (1)	JP3858279B2 (de)
KR (1)	KR100345187B1 (de)
CN (1)	CN1084620C (de)
AT (1)	ATE273708T1 (de)
AU (1)	AU1718395A (de)
CA (1)	CA2183234C (de)
DE (1)	DE69533392T2 (de)
DK (1)	DK0744950T3 (de)
ES (1)	ES2222464T3 (de)
FI (1)	FI116882B (de)
IL (1)	IL112695A (de)
NO (1)	NO311490B1 (de)
WO (1)	WO1995022329A1 (de)
ZA (1)	ZA951470B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW482675B (en) *	1997-01-31	2002-04-11	Green Cross Corp	Compositions for oral administration containing pyridazinone compounds technical field of the invention
US6284758B1 (en) *	1997-08-28	2001-09-04	Welfide Corporation	Angiogenesis promoters and angiogenesis potentiators
US6143113A (en)	1998-03-02	2000-11-07	Le Groupe Recherche I.D. Inc.	Repulpable corrugated boxboard
DE69919191T2 (de) *	1998-09-01	2005-07-28	Nissan Chemical Industries, Ltd.	Heilmittel für die stenose des rückenmarkkanals
WO2000033845A1 (en) *	1998-12-07	2000-06-15	Nissan Chemical Industries, Ltd.	Remedial agent for erectile dysfunction
CN1897952B (zh) *	2003-12-26	2010-12-08	日产化学工业株式会社	中性白细胞增多抑制剂
JP2011510994A (ja) *	2008-01-29	2011-04-07	インディゴファーマシューティカルズ	末梢動脈疾患の治療のためのｐｄｅ３阻害剤の増減投与方法
CN113546049B (zh) *	2021-04-30	2023-03-17	贵州汉方药业有限公司	一种柔性丸剂药物黏合剂及使用该黏合剂制成的柔性丸剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4599336A (en) *	1983-08-08	1986-07-08	Hoffmann-La Roche Inc.	Derivatives of (E)-3-(4-oxo-4H-quinazolin-3-yl)-2-propenamide
EP0142057A3 (de) *	1983-11-04	1988-03-30	F. Hoffmann-La Roche Ag	Thiazolochinazolin-Derivate, ihre Herstellung und sie enthaltende pharmazeutische Zubereitungen
US4978665A (en) *	1987-01-20	1990-12-18	Nissan Chemical Industries Ltd.	3(2H)pyridazinone, and antagonistic agent against SRS-A containing it
JPH02256668A (ja) *	1988-12-20	1990-10-17	Nissan Chem Ind Ltd	ピリダジノン誘導体
ES2149761T3 (es) *	1990-04-25	2000-11-16	Nissan Chemical Ind Ltd	Derivado de piridazinona.

1995
- 1995-02-19 IL IL11269595A patent/IL112695A/xx not_active IP Right Cessation
- 1995-02-20 WO PCT/JP1995/000244 patent/WO1995022329A1/en not_active Ceased
- 1995-02-20 US US08/687,604 patent/US5798357A/en not_active Expired - Lifetime
- 1995-02-20 CA CA002183234A patent/CA2183234C/en not_active Expired - Lifetime
- 1995-02-20 AU AU17183/95A patent/AU1718395A/en not_active Abandoned
- 1995-02-20 AT AT95909122T patent/ATE273708T1/de active
- 1995-02-20 DE DE69533392T patent/DE69533392T2/de not_active Expired - Lifetime
- 1995-02-20 CN CN95191744A patent/CN1084620C/zh not_active Expired - Lifetime
- 1995-02-20 DK DK95909122T patent/DK0744950T3/da active
- 1995-02-20 ES ES95909122T patent/ES2222464T3/es not_active Expired - Lifetime
- 1995-02-20 EP EP95909122A patent/EP0744950B1/de not_active Expired - Lifetime
- 1995-02-20 KR KR1019960704529A patent/KR100345187B1/ko not_active Expired - Lifetime
- 1995-02-21 JP JP03230095A patent/JP3858279B2/ja not_active Expired - Fee Related
- 1995-02-22 ZA ZA951470A patent/ZA951470B/xx unknown
1996
- 1996-08-20 NO NO19963463A patent/NO311490B1/no not_active IP Right Cessation
- 1996-08-21 FI FI963264A patent/FI116882B/fi not_active IP Right Cessation

Also Published As

Publication number	Publication date
CA2183234C (en)	2004-05-04
FI963264A7 (fi)	1996-08-21
JP3858279B2 (ja)	2006-12-13
FI963264A0 (fi)	1996-08-21
EP0744950A1 (de)	1996-12-04
CN1141590A (zh)	1997-01-29
DE69533392T2 (de)	2005-09-01
CA2183234A1 (en)	1995-08-24
EP0744950B1 (de)	2004-08-18
CN1084620C (zh)	2002-05-15
IL112695A0 (en)	1995-05-26
WO1995022329A1 (en)	1995-08-24
FI116882B (fi)	2006-03-31
DK0744950T3 (da)	2004-10-25
KR970701048A (ko)	1997-03-17
IL112695A (en)	1999-04-11
NO311490B1 (no)	2001-12-03
US5798357A (en)	1998-08-25
KR100345187B1 (ko)	2002-12-05
ES2222464T3 (es)	2005-02-01
JPH07285869A (ja)	1995-10-31
ZA951470B (en)	1995-12-07
AU1718395A (en)	1995-09-04
DE69533392D1 (de)	2004-09-23
NO963463L (no)	1996-08-20

Legal Events

Date

Code

Title

Description

2005-05-15

UEP

Publication of translation of european patent specification

Ref document number: 0744950

Country of ref document: EP

Publication	Publication Date	Title
GB9408577D0 (en)	1994-06-22	New compound
ATE443043T1 (de)	2009-10-15	Phenylcarboxamide als beta-sekretase-hemmer zur behandlung von alzheimer
KR950702180A (ko)	1995-06-19	류코트리엔 생합성 억제제로서의 치환된 아릴알키닐-및 헤테로아릴알키닐-N-하이드록시우레아(substituted arylalkynyl-and heteroarylalkyny-N-hydroxyurea inhibi tors of leukotriene biosynthesis)본 내용은 요부공개 건이므로 전문 내용을 수록하지 않았음
IL112841A0 (en)	1995-06-29	Sulfonamide aspartyl protease inhibitors methods for the preparation thereof and pharmaceutical compositions containing the same
DE59409312D1 (de)	2000-05-31	Imidazopyridine und ihre anwendung zur behandlung von magen-darm krankheiten
GEP20053619B (en)	2005-09-26	Pyrazole Derivatives for Treating HIV
MXPA04006553A (es)	2004-10-04	Compuesto de 4-oxoquinolina y uso del mismo como inhibidor de integrasa de vih.
ATE273708T1 (de)	2004-09-15	Wirkstoff zur prophylaxis und behandlung von krankheiten durch thromboxane a2 vermittelt
ATE245447T1 (de)	2003-08-15	Inhibitor von gehirnödemen
DE60318874D1 (en)	2008-03-13	Pyrazolderivate
DE69315836D1 (de)	1998-01-29	Pyrazolpyridine für die behandlung der anämie
NO975726D0 (no)	1997-12-05	N-Hydroksyurea-derivater som anti-inflammatoriske midler
DK0720598T3 (da)	1999-06-21	Phenoxyphenylcyclopentenyl-hydroxyurinstoffer
DE69400704D1 (de)	1996-11-14	N-acylpyrrolidine und arzneimittel zur behandlung oder prophylaxe von mit ckk und gastrin in zusammenhang stehenden krankheiten
AU2003263455A1 (en)	2004-04-19	Pyrazole amides for treating hiv infections
DK0632717T3 (da)	1999-02-22	Middel til anvendelse som et anti-irritationsmiddel
EP1325918A4 (de)	2004-03-10	Herzmuskelzellen-apoptose hemmstoffe und behandlung/vorbeugung von herzkrankheiten
GB0223234D0 (en)	2002-11-13	Chemical compounds